MYIMATINIB BECAUSE NO TWO PATIENTS ARE ALIKE
Dead / Abandoned — Abandoned — no statement of use filed (as of 28 Apr 2014)
What this means for you
This application is over — abandoned 28 Apr 2014. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85847199
- Mark type
- Design + words
- Filed
- 12 Feb 2013
- Published for opposition
- 30 Jul 2013
- Abandoned
- 28 Apr 2014
- Attorney of record
- Vanessa A. Ignacio, Esquire
Goods and services
- Class 042 — Scientific and technological services: Medical laboratory services; Medical laboratory services to determine the concentration of the drug imatinib mesylate in the blood of cancer patients
Owner
- SALADAX BIOMEDICAL, INC., Bethlehem, PA, US
- SALADAX BIOMEDICAL, INC., Bethlehem, PA, US
Prior registrations
Prosecution history
- 28 Apr 2014 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 28 Apr 2014 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Sept 2013 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jul 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jul 2013 — PUBLISHED FOR OPPOSITION
- 10 Jul 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jun 2013 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 19 Jun 2013 — ASSIGNED TO LIE
- 04 Jun 2013 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Jun 2013 — EXAMINER'S AMENDMENT ENTERED
- 04 Jun 2013 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Jun 2013 — EXAMINERS AMENDMENT E-MAILED
- 04 Jun 2013 — EXAMINERS AMENDMENT -WRITTEN
- 28 May 2013 — ASSIGNED TO EXAMINER
- 20 Feb 2013 — NOTICE OF DESIGN SEARCH CODE E-MAILED